Drug Shortage Report for TEVA-NARATRIPTAN
Report ID | 128632 |
Drug Identification Number | 02314290 |
Brand name | TEVA-NARATRIPTAN |
Common or Proper name | Naratriptan Tablets |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NARATRIPTAN |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | P/PACK 8 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-11-18 |
Estimated end date | 2021-01-31 |
Actual end date | 2021-01-20 |
Shortage status | Resolved |
Updated date | 2021-01-21 |
Company comments | Product is short-dated, new product coming at end of 2020 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-01-21 | French | Compare |
v5 | 2021-01-21 | English | Compare |
v4 | 2021-01-07 | French | Compare |
v3 | 2021-01-07 | English | Compare |
v2 | 2020-11-19 | French | Compare |
v1 | 2020-11-19 | English | Compare |
Showing 1 to 6 of 6